- Field Trip Health (FTRP) has launched its KAP Co-operative Program enabling psychedelic therapists to practice at its health centers
- Eligible psychedelic therapists will be able to provide their patients with ketamine-assisted psychotherapy
- They may also take part in training programs on the therapy itself
- The first training session will take place on the weekend of October 8, 2021, in Seattle, Washington
- Field Trip is a global leader in the development and delivery of psychedelic therapies
- Field Trip Health (FTRP) is up by 4.08 per cent and is currently trading at $5.87 per share
Field Trip Health (FTRP) has launched its KAP Co-operative Program enabling psychedelic therapists to practice at its health centers.
Eligible psychedelic therapists will be able to provide their patients with ketamine-assisted psychotherapy, as well as take part in training programs on the therapy itself.
Topics covered in the training programs include preparation for psychedelic therapy, techniques for guiding a psychedelic experience, and integration of insights from a psychedelic experience.
The first session will take place on the weekend of October 8, 2021, in Seattle, Washington, and will cost US$1,200. Future sessions will be held at Field Trip Health center locations.
KAP eligibility will be determined through experience or approved training programs through MAPS, Fluence, The Ketamine Training Center and the California Institute for Integral Studies, among others.
Medical screening and ketamine administration/dispensation at a Field Trip Health center for co-op clients will be available for an introductory price of US$400.
Hannan Fleiman, Field Trip’s President, commented,
“The launch of the KAP Co-op Program extends Field Trip’s presence to a whole new population of therapists and their clients, who want to have the Field Trip experience and access our world class Field Trip Health centers. Now, instead of operating in parallel to existing client-therapist relationships, Field Trip is working on a truly complementary and co-operative basis to the incredible work all psychedelic therapists are doing with their clients.”
Field Trip is a global leader in the development and delivery of psychedelic therapies.
Field Trip Health (FTRP) is up by 4.08 per cent and is currently trading at $5.87 per share as of 9:30 am ET.
